Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Noom, an online weight loss company, will now be selling small doses of compounded versions of Wegovy, the prescription medication developed by Novo Nordisk
If you don't qualify for GLP-1s, you shouldn't jump through hoops to get a prescription
Important considerations for ongoing treatment: Regular review with the prescribing healthcare professional is essential Treatment should be discontinued if no clear benefit is observed after an adequate trial period (typically 812 weeks) Do not delay seeking medical attention for new or worsening symptoms Be alert to red flag symptoms requiring urgent assessment, such as unexplained weight loss, persistent fever, chest pain, or suicidal thoughts Patients should maintain realistic expectations , recognising that robust evidence for clinical benefits remains limited
INTERACTIONS Spurdle et al
While these mechanisms can explain the protective effect that GLP-1 RA exposure had on the fracture risk of the exposed patients in our study, it is important to consider the fact that the findings mentioned were from studies primarily conducted on patients prescribed GLP-1 RA who had a diagnosis of T2DM, as this is what the drugs were originally FDA-approved to treat
Boosting GIPR activity could directly affect the myocardium and indirectly influence cardiovascular function and outcomes through its systemic effects on other organs [13]
